comparemela.com

Latest Breaking News On - Sinaptica therapeutics - Page 2 : comparemela.com

Sinaptica Therapeutics obtains FDA Breakthrough Device Designation for Alzheimer's treatment

The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.

Cambridge-based-sinaptica-therapeutics
Device-designation
Sinaptica-therapeutics
Primary-relief

Sinaptica's neurostim for Alzheimer's wins FDA breakthrough nod

Sinaptica Therapeutics announced today that it received FDA breakthrough device designation for its investigational SinaptiStim AD system.

Italy
Boston
Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Rome
Lazio
Giacamo-koch
Emiliano-santarnecchi
Santa-lucia-foundation

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.